indium [in-111] pentetate (dtpa) 37mbq/1ml solution for injection vials
dtpa) 37mbq/1ml solution for injection vials (curium pharma uk ltd - indium [in-111] pentetate (dtpa) - solution for injection - 37mbq/1ml
indium chloride sterile
ge healthcare limited - indium (111 in) chloride solution - radio-pharm precursor - 370 mbq/ml
indium oxine
ge healthcare limited - indium oxine (in-111) - radio-pharm precursor
octreoscan- indium in -111 pentetreotide kit
curium us llc - indium in-111 pentetreotide (unii: m312jj6z32) (indium in-111 pentetreotide - unii:m312jj6z32) - pentetreotide 10 ug in 1 ml - octreoscan, after radiolabeling, is an agent for the scintigraphic localization of primary and metastatic neuroendocrine tumors bearing somatostatin receptors. none known.
high purity indium chloride in 111 sterile solution
curium canada inc - indium in 111 chloride - solution - 10mci - indium in 111 chloride 10mci - radioactive agents
octreoscan 111 mbq/ml, kit for radiopharmaceutical preparation
curium netherlands b.v. - indium (111 in) chloride solution; pentetreotide - kit for radiopharmaceutical preparation - 111 megabecquerel(s)/millilitre - indium (111in) pentetic acid
octreoscan injection composite pack with needle
landauer radiopharmaceuticals pty ltd - indium (111in) chloride,pentetreotide -
ari indium (111in) pentetate 37mbq/ml injection multidose vial
ansto t/a ansto health - indium(111in) pentetate -
in-111 dtpa solution
anazaohealth corporation - indium in-111 pentetate disodium (unii: 7uit3zgc8e) (pentetic acid - unii:7a314hqm0i) - indium in-111 pentetate disodium 3.75 mci in 1.5 ml - in-111 dtpa is indicated for use in radionuclide cisternography there are no known contraindications
octreoscan solution
curium canada inc - indium in 111 chloride; pentetreotide - solution - 111mbq; 10mcg - indium in 111 chloride 111mbq; pentetreotide 10mcg - roentgenography